Citizens Maintains Market Outperform on BeOne Medicines, Raises Price Target to $405

Benzinga · 2d ago
Citizens analyst Reni J. Benjamin maintains BeOne Medicines (NASDAQ:ONC) with a Market Outperform and raises the price target from $396 to $405.